| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
1 | 2022 | Structural determination of an antibody that specifically recognizes polyethylene glycol with a terminal methoxy group | Nguyen, MT; Shih, YC; Lin, MH; Roffler, SR ; Hsiao, CY; Cheng, TL; Lin, WW; Lin, EC; Jong, YJ; Chang, CY; Su, YC | Communications chemistry 5(1), 88 | | | |
2 | 2021 | Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity | Ho, KW; Chen, IU; Cheng, YA; Liao, TY; Liu, ES; Chen, HJ; Lu, YC; Su, YC; Roffler, SR ; Huang, BC; Liu, HJ; Huang, MY; Chen, CY; Cheng, TL | Journal of nanobiotechnology 19, 16 | | | |
3 | 2020 | Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex | Chen, E; Chen, BM; Su, YC; Chang, YC ; Cheng, TL; Barenholz, Y; Roffler, SR | ACS nano 14(7), 7808-7822 | | | |
4 | 2019 | Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer. | Cheng, YA; Chen, IJ; Su, YC; Cheng, KW; Lu, YC; Lin, WW; Hsieh, YC; Kao, CH; Chen, FM; Roffler, SR ; Cheng, TL | Biomaterials science 7(8), 3404-3417 | | | |
5 | 2017 | Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy. | Su, YC; Burnouf, PA; Chuang, KH; Chen, BM; Cheng, TL; Roffler, SR | NATURE COMMUNICATIONS 8, 15507 | | | |